vs
Side-by-side financial comparison of PLUS THERAPEUTICS, INC. (PSTV) and AgEagle Aerial Systems Inc. (UAVS). Click either name above to swap in a different company.
AgEagle Aerial Systems Inc. is the larger business by last-quarter revenue ($2.0M vs $1.4M, roughly 1.4× PLUS THERAPEUTICS, INC.). AgEagle Aerial Systems Inc. runs the higher net margin — -132.7% vs -417.9%, a 285.2% gap on every dollar of revenue. On growth, PLUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (-3.2% vs -40.0%). AgEagle Aerial Systems Inc. produced more free cash flow last quarter ($-3.3M vs $-6.3M). Over the past eight quarters, PLUS THERAPEUTICS, INC.'s revenue compounded faster (-9.7% CAGR vs -17.9%).
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecu...
Elbit Systems Ltd. is an Israel-based international military technology company and defense contractor. Founded in 1966 by Elron, Elbit Systems is the primary provider of the Israeli military's land-based equipment and unmanned aerial vehicles. It is an important company within the defense industry of Israel.
PSTV vs UAVS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4M | $2.0M |
| Net Profit | $-5.7M | $-2.6M |
| Gross Margin | — | 38.5% |
| Operating Margin | -420.0% | -160.1% |
| Net Margin | -417.9% | -132.7% |
| Revenue YoY | -3.2% | -40.0% |
| Net Profit YoY | -46.4% | 24.4% |
| EPS (diluted) | $0.95 | $-0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4M | — | ||
| Q3 25 | $1.4M | $2.0M | ||
| Q2 25 | $1.4M | $4.2M | ||
| Q1 25 | $1.1M | $3.6M | ||
| Q4 24 | $1.4M | $2.8M | ||
| Q3 24 | $1.5M | $3.3M | ||
| Q2 24 | $1.3M | $3.4M | ||
| Q1 24 | $1.7M | $3.9M |
| Q4 25 | $-5.7M | — | ||
| Q3 25 | $-4.4M | $-2.6M | ||
| Q2 25 | $5.2M | $-1.3M | ||
| Q1 25 | $-17.4M | $7.1M | ||
| Q4 24 | $-3.9M | $-22.3M | ||
| Q3 24 | $-2.9M | $-3.5M | ||
| Q2 24 | $-2.9M | $-2.9M | ||
| Q1 24 | $-3.3M | $-6.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | 38.5% | ||
| Q2 25 | — | 55.7% | ||
| Q1 25 | — | 58.5% | ||
| Q4 24 | — | 40.6% | ||
| Q3 24 | — | 49.7% | ||
| Q2 24 | — | 45.8% | ||
| Q1 24 | — | 50.2% |
| Q4 25 | -420.0% | — | ||
| Q3 25 | -320.8% | -160.1% | ||
| Q2 25 | -110.6% | -49.3% | ||
| Q1 25 | -333.9% | -27.5% | ||
| Q4 24 | -276.2% | -207.0% | ||
| Q3 24 | -260.9% | -56.7% | ||
| Q2 24 | -289.1% | -74.9% | ||
| Q1 24 | -196.7% | -61.5% |
| Q4 25 | -417.9% | — | ||
| Q3 25 | -316.6% | -132.7% | ||
| Q2 25 | 370.6% | -30.5% | ||
| Q1 25 | -1643.2% | 193.5% | ||
| Q4 24 | -276.4% | -791.9% | ||
| Q3 24 | -197.4% | -105.3% | ||
| Q2 24 | -229.9% | -86.4% | ||
| Q1 24 | -194.5% | -162.2% |
| Q4 25 | $0.95 | — | ||
| Q3 25 | $-0.04 | $-0.09 | ||
| Q2 25 | $-0.01 | $-0.32 | ||
| Q1 25 | $-1.19 | $-0.09 | ||
| Q4 24 | $-0.51 | $52.35 | ||
| Q3 24 | $-0.37 | $-16.03 | ||
| Q2 24 | $-0.71 | $-12.06 | ||
| Q1 24 | $-0.75 | $-70.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.0M | $28.3M |
| Total Assets | $16.3M | $34.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.6M | — | ||
| Q3 25 | $16.6M | — | ||
| Q2 25 | $6.9M | — | ||
| Q1 25 | $9.9M | $3.8M | ||
| Q4 24 | $3.6M | $3.6M | ||
| Q3 24 | $4.8M | $265.1K | ||
| Q2 24 | $8.4M | $977.2K | ||
| Q1 24 | $3.2M | $822.9K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $420.4K | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $4.0M | — | ||
| Q3 25 | $5.1M | $28.3M | ||
| Q2 25 | $3.0M | $16.3M | ||
| Q1 25 | $-23.6M | $4.2M | ||
| Q4 24 | $-8.9M | $-5.7M | ||
| Q3 24 | $-5.2M | $6.2M | ||
| Q2 24 | $-7.6M | $8.1M | ||
| Q1 24 | $-4.8M | $9.1M |
| Q4 25 | $16.3M | — | ||
| Q3 25 | $18.7M | $34.5M | ||
| Q2 25 | $10.3M | $23.2M | ||
| Q1 25 | $12.1M | $20.2M | ||
| Q4 24 | $6.6M | $20.6M | ||
| Q3 24 | $7.0M | $22.0M | ||
| Q2 24 | $11.2M | $22.8M | ||
| Q1 24 | $5.6M | $23.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.10× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.3M | $-3.3M |
| Free Cash FlowOCF − Capex | $-6.3M | $-3.3M |
| FCF MarginFCF / Revenue | -459.9% | -168.0% |
| Capex IntensityCapex / Revenue | 2.2% | 0.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-20.8M | $-9.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.3M | — | ||
| Q3 25 | $-2.5M | $-3.3M | ||
| Q2 25 | $-5.8M | $-2.7M | ||
| Q1 25 | $-6.2M | $-1.3M | ||
| Q4 24 | $-1.2M | $-2.5M | ||
| Q3 24 | $-3.7M | $-1.1M | ||
| Q2 24 | $-1.1M | $-1.4M | ||
| Q1 24 | $-4.5M | $-1.6M |
| Q4 25 | $-6.3M | — | ||
| Q3 25 | $-2.6M | $-3.3M | ||
| Q2 25 | $-5.8M | $-2.8M | ||
| Q1 25 | $-6.2M | $-1.3M | ||
| Q4 24 | $-1.2M | $-2.5M | ||
| Q3 24 | $-3.7M | $-1.1M | ||
| Q2 24 | $-1.2M | $-1.4M | ||
| Q1 24 | $-4.6M | $-1.6M |
| Q4 25 | -459.9% | — | ||
| Q3 25 | -184.3% | -168.0% | ||
| Q2 25 | -417.6% | -65.7% | ||
| Q1 25 | -583.1% | -35.8% | ||
| Q4 24 | -86.5% | -89.7% | ||
| Q3 24 | -253.7% | -32.7% | ||
| Q2 24 | -96.2% | -42.5% | ||
| Q1 24 | -271.5% | -40.5% |
| Q4 25 | 2.2% | — | ||
| Q3 25 | 1.9% | 0.7% | ||
| Q2 25 | 0.5% | 0.3% | ||
| Q1 25 | 0.3% | 0.3% | ||
| Q4 24 | 0.8% | 0.5% | ||
| Q3 24 | 1.0% | 0.0% | ||
| Q2 24 | 6.3% | 0.4% | ||
| Q1 24 | 2.4% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.13× | — | ||
| Q1 25 | — | -0.18× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PSTV
Segment breakdown not available.
UAVS
| Drones Segment | $1.1M | 54% |
| Other | $912.5K | 46% |
